Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-us/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

Multiple Sclerosis

Multiple Sclerosis or MS is an inflammatory disease of the brain and spinal cord (central nervous system).

In MS, the immune systems attacks the protective sheath (myelin) or insulating layer that protects nerves in the body, causing communication problems between the brain and rest of the body, and can eventually create neurological issues and impairments.

Symptoms will vary as not everyone experiences MS the same. Symptoms can range from mild to severe and are determined by location of the nerve damage.

Bladder Dysfunction in MS

Bladder problems occur in at least 80% of people with MS. Lesions created by this condition can either block or delay the communication of nerve signals including those that control the urinary sphincter and bladder; this impacts the bladders ability to storage and/or empty urine properly.

There are a few types of bladder problems that can affect MS patients:

  • over‐active bladder (urinary incontinence)
  • incomplete bladder drainage (urinary retention)
  • neurogenic bladder

Bladder Management and Treatment Options

Bladder symptoms can usually be managed successfully with lifestyle modifications, medications, physical therapy and/or nerve stimulation procedures. Always speak with a healthcare provider to select the optimal treatment approach after a careful assessment of bladder symptoms.

Options may include:

  • Medications in a variety of forms are available to address specific bladder symptoms in MS.
  • Pelvic floor physical therapy (often prescribed for spastic or overactive bladder symptoms) targets the group of muscles attached to the pelvic bone and sacrum that rule bladder and bowel function.
  • Percutaneous tibial nerve stimulation (PTNS) (for symptoms of spastic or overactive bladder), designed to stimulate the nerves responsible for bladder control using the tibial nerve in your lower leg.
  • Intermittent self‐catheterization may be recommended for difficulty emptying the bladder. Using an intermittent catheter one or more times per day can help control bladder leakage, urgency and frequency, and nighttime urination in people who cannot completely empty their bladder on their own.
  • Other surgical interventions are available to address urinary problems that do not respond adequately to any of these interventions.

If experiencing bladder problems, like urinary retention or incomplete bladder emptying, speaking with a healthcare professional is most important to discuss what options may be best for you.

Enroll in me+™ or Request Product Samples

The me+™ support program offers tools to help make life as a catheter user completely your own. Enroll in me+™ or request free product samples. Experience the latest technology and discover answers to the most commonly asked cathing questions.

Adjusting to cathing can be tough, with a range of practical, physical and emotional challenges. You don’t have to figure it out alone.

Speak with a member of the me+™ support team today.

Call 1-800-422-8811 (M-F, 8:30 AM-7:00 PM ET).

Contact Us

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?